Biotech Stocks: Mylan, King lead drug stocks higher. Drug stocks advanced in early action Thursday, led by Mylan Laboratories and King Pharmaceuticals.

Counterfeit Medicines - Report Urges No Compromise And No Concession.. EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the release of the Europe Economics report on 'Safe Medicines Through Parallel Trade'i. The report clearly highlights the risks..

Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline. Par Pharmaceutical Companies, Inc. today announced a resizing of its generic unit as part of an ongoing strategic assessment of its businesses.

Synta Pharmaceuticals Earns $25 Million from GlaxoSmithKline for Achieving Elesclomol Milestones. Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has achieved..

Zacks Analyst Blog Highlights: Actions Semiconductor Corp., Barr.. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

FDA Approves AstraZeneca's Seroquel XR for the Treatment of.. AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar..

NSAIDs Might Lower Breast Cancer Risk. Non-steroidal anti-inflammatory drugs are associated with a reduced risk for breast cancer, a new review suggests.

Release date set for NAOMI heroin project results. Several groups advocating the downtrodden of Vancouver's Downtown Eastside released Friday what they claimed were key findings from a trial project that provided prescription heroin to addicts.

Australia begins bottled beer, sunscreen exports to India. South East Asia News.Net Thursday 9th October, 2008 Two iconic products of the Australian lifestyle, sunscreen and beer, are the latest to join the growing list of exports strengthening the economic ties..

Izard Nobel LLP Announces Class Action Lawsuit against Biovail Corporation. HARTFORD, Conn. The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has..

Acura Pharmaceuticals And King Pharmaceuticals Announce Positive Top.. PALATINE, ILLINOIS and BRISTOL, TENNESSEE October 13, 2008 Acura Pharmaceuticals, Inc.

88.7% Of Ulcerative Colitis Patients In Remission Remained Relapse-Free At 12 Months With Once Daily Mezavant XL. Shire Limited, the global specialty biopharmaceutical company, announces that data published in Gut show that 64.4% of patients with mild to moderate ulcerative colitis who achieved clinical and endoscopic remission maintained this at 12 months when given two mesalazine 1200mg gastro-resistant, prolonged release tablets once a day as a maintenance therapy.

Ranolazine For Angina Treatment. Ranolazine, a new treatment for chronic, stable angina, is discussed as a safe and effective option for patients in a New Drug Class paper released on October 10, 2008 in The Lancet. Chronic stable angina is a prolonged chest pain which is often linked to heart disease. It is often present when the patient is exercising. This kind of angina is highly prevalent in developed nations, and in the United States, 9.1 million have the condition.

Solvents May Cause Brain Disorders, But Rehabilitation Is Possible. There is little experience with the psychological treatment of patients with solvent-induced chronic toxic encephalopathy. This randomised controlled trial evaluates a treatment programme based on previous outcome studies of patients with chronic fatigue, whiplash and traumatic brain damage.

FDA Continues Review Of Takeda's New Drug Application For Alogliptin, A DPP-4 Agent For Type 2 Diabetes. Takeda Pharmaceutical Company Limited announced that Takeda Global Research and Development Center, Inc., a wholly owned United States subsidiary, received notification that the U.S. Food and Drug Administration will not be able to complete its review of the alogliptin New Drug Application by the Prescription Drug User Fee Act date of October 27, 2008.

Ranolazine Safe And Effective For Angina. Researchers from Syracuse Preventive Medicine, NY, USA discuss a new drug called ranolazine that has been deemed a safe and effective treatment for chronic stable angina. Drs Stephen Nash and David Nash discuss this new treatment option in a New Drug Class paper published in The Lancet. Angina is characterized by severe chest pain caused by a lack of blood and oxygen supply to the heart muscle, often due to ischemic heart disease.

Cyclacel Announces Completion Of Enrollment In Phase 2 Trial Of Sapacitabine In Elderly AML. lCyclacel Pharmaceuticals, Inc. announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly patients with acute myeloid leukemia. Interim results from this trial are expected to be available by the end of 2008 and final results during the second half of 2009.

In Growing 80-Plus Population Study Finds Stroke-Prevention Surgery To Be Safe. New research published in the October issue of Journal of the American College of Surgeons challenges the current opinion that patients in their eighties, who are often deemed "high-risk" due to their advanced age, should not undergo carotid endarterectomy - a stroke-preventing surgical procedure that clears blockages from the neck's carotid arteries.

Traffic Noise Places 1 In 6 San Francisco Residents At Risk For Various Stress-Related Ailments. One in 6 San Francisco residents risk acquiring a heart problem, high blood pressure and other stress-related ailments, according to city public health officials. The culprit is the city's noise pollution emanating from its traffic. Wed, 8 Oct 2008 10:48:04 GMT.

Canada Continues To Wage Battle Against Listeria. While China and the rest of the world are grappling with the melamine scare found in milk and dairy products, Canada's health battle is still against the deadly listeria. Thu, 9 Oct 2008 13:54:58 GMT.